Our findings add to previous evidence that insomnia pathologically leads to elevated Aβ levels in the cerebrospinal fluid and induces aggregation of Aβ peptides and tau proteins (Di Meco et al., 2014; Chen et al., 2018). The gene discussed is MAPT; the disease is insomnia measurement.